ロード中...

Disrupting BCR-ABL in Combination with Secondary Leukemia-Specific Pathways in CML Cells Leads to Enhanced Apoptosis and Decreased Proliferation

Chronic myeloid leukemia (CML) is a myeloproliferative disorder caused by expression of the fusion gene BCR-ABL following a chromosomal translocation in the hematopoietic stem cell.(1) Therapeutic management of CML uses tyrosine kinase inhibitors (TKIs), which blocks ABL-signaling and effectively ki...

詳細記述

保存先:
書誌詳細
主要な著者: Woessner, David W., Lim, Carol S.
フォーマット: Artigo
言語:Inglês
出版事項: 2012
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3604893/
https://ncbi.nlm.nih.gov/pubmed/23211037
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp300405n
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!